MagVenture Inc., a provider of transcranial magnetic stimulation, has received clearance from the US Food and Drug Administration for a new protocol that cuts the time of each treatment session down to 3 minutes, the company announced.
Adults age 50 and older with vitamin D deficiency have a 75% increased risk of developing depression over the next 4 years, a longitudinal study suggests.
High-dose antipsychotic use in children and young adults without psychosis is associated with an increased risk of unexpected death, according to a study published online in JAMA Psychiatry.
The effectiveness of the vast majority of self-care interventions suggested for children and young people with anxiety and depression has not been evaluated, new research shows.
Greater depressive and anxiety symptoms at baseline predicted a better response to treatment with synchronized transcranial magnetic stimulation (sTMS) for major depressive disorder (MDD), according to a study.
Older adults who are prescribed medication for depression by primary care physicians often fail to initiate them or to continue using them as directed, a Dutch study suggests.